Published in Nature on May 30, 1984
The protein encoded by the human proto-oncogene c-myc. Proc Natl Acad Sci U S A (1984) 3.31
Involvement of c-myc in MuLV-induced T cell lymphomas in mice: frequency and mechanisms of activation. EMBO J (1984) 3.28
Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas. EMBO J (1985) 2.47
Patterns of proviral insertion and deletion in avian leukosis virus-induced lymphomas. J Virol (1986) 1.93
Characterization and chromosome assignment of the human homolog of int-2, a potential proto-oncogene. Mol Cell Biol (1986) 1.90
Augmented expression of normal c-myc is sufficient for cotransformation of rat embryo cells with a mutant ras gene. Mol Cell Biol (1985) 1.84
Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene. Proc Natl Acad Sci U S A (1997) 1.69
High-frequency transduction of c-erbB in avian leukosis virus-induced erythroblastosis. J Virol (1985) 1.69
Concerted DNA rearrangements in Moloney murine leukemia virus-induced thymomas: a potential synergistic relationship in oncogenesis. J Virol (1985) 1.67
Transformation of mammalian fibroblasts and macrophages in vitro by a murine retrovirus encoding an avian v-myc oncogene. EMBO J (1984) 1.55
Trans-acting elements modulate expression of the human c-myc gene in Burkitt lymphoma cells. Proc Natl Acad Sci U S A (1986) 1.53
Quantitative Expression and Co-Localization of Wnt Signalling Related Proteins in Feline Squamous Cell Carcinoma. PLoS One (2016) 1.40
Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma. J Virol (1996) 1.30
Recombinant feline leukemia virus genes detected in naturally occurring feline lymphosarcomas. J Virol (1993) 1.28
Nucleotide sequence and distinctive characteristics of the env gene of endogenous feline leukemia provirus. J Virol (1989) 1.22
Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression. J Virol (1991) 1.20
Structural diversity and nuclear protein binding sites in the long terminal repeats of feline leukemia virus. J Virol (1990) 1.17
Nucleotide sequence of two overlapping myc-related genes in avian carcinoma virus OK10 and their relation to the myc genes of other viruses and the cell. Proc Natl Acad Sci U S A (1985) 1.16
Modulation of feline immunodeficiency virus infection by stromal cell-derived factor. J Virol (1998) 1.11
Identification of a putative cellular receptor for feline immunodeficiency virus as the feline homologue of CD9. Immunology (1994) 1.09
Enhanced c-Ki-ras expression associated with Friend virus integration in a bone marrow-derived mouse cell line. Proc Natl Acad Sci U S A (1986) 1.09
Recombinant murine retroviruses containing avian v-myc induce a wide spectrum of neoplasms in newborn mice. Proc Natl Acad Sci U S A (1986) 1.08
Genetic determinants of feline leukemia virus-induced lymphoid tumors: patterns of proviral insertion and gene rearrangement. J Virol (1994) 1.07
Identification of a provirally activated c-Ha-ras oncogene in an avian nephroblastoma via a novel procedure: cDNA cloning of a chimaeric viral-host transcript. EMBO J (1986) 1.06
Localization of neutralizing regions of the envelope gene of feline leukemia virus by using anti-synthetic peptide antibodies. J Virol (1987) 1.04
Nucleotide sequence of a transduced myc gene from a defective feline leukemia provirus. J Virol (1985) 1.03
Accurate and efficient transcription of human c-myc genes injected into Xenopus laevis oocytes. Mol Cell Biol (1985) 1.00
Features of the chicken c-myc gene that influence the structure of c-myc RNA in normal cells and bursal lymphomas. Mol Cell Biol (1986) 1.00
Nuclear factor 1 activates the feline leukemia virus long terminal repeat but is posttranscriptionally down-regulated in leukemia cell lines. J Virol (1991) 0.99
Rearrangement and expression of erythropoietin genes in transformed mouse cells. Mol Cell Biol (1987) 0.99
Feline glucose-6-phosphate dehydrogenase cellular mosaicism. Application to the study of retrovirus-induced pure red cell aplasia. J Clin Invest (1985) 0.97
Induction of nephroblastoma by myeloblastosis-associated virus type 1: state of proviral DNAs in tumor cells. J Virol (1989) 0.95
Transforming potential of a myc-containing variant of feline leukemia virus in vitro in early-passage feline cells. J Virol (1987) 0.93
gag as well as myc sequences contribute to the transforming phenotype of the avian retrovirus FH3. J Virol (1992) 0.92
Long-range effects of retroviral insertion on c-myb: overexpression may be obscured by silencing during tumor growth in vitro. J Virol (2003) 0.92
Moloney murine leukemia virus-induced lymphomas in p53-deficient mice: overlapping pathways in tumor development? J Virol (1996) 0.92
Selection for c-myc integration sites in polyclonal T-cell lymphomas. J Virol (2002) 0.92
Structure, origin, and transforming activity of feline leukemia virus-myc recombinant provirus FTT. J Virol (1989) 0.92
Fim-1, Fim-2/c-fms, and Fim-3, three common integration sites of Friend murine leukemia virus in myeloblastic leukemias, map to mouse chromosomes 13, 18, and 3, respectively. J Virol (1988) 0.90
Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice. J Virol (2001) 0.89
Differential promoter utilization by the c-myc gene in mitogen- and interleukin-2-stimulated human lymphocytes. Mol Cell Biol (1987) 0.89
Insertional mutagenesis of flvi-2 in tumors induced by infection with LC-FeLV, a myc-containing strain of feline leukemia virus. J Virol (1992) 0.88
The myc proteins are not associated with chromatin in mitotic cells. EMBO J (1984) 0.87
Tumorigenic potential of a myc-containing strain of feline leukemia virus in vivo in domestic cats. J Virol (1988) 0.87
Pathogenesis of feline leukemia virus T17: contrasting fates of helper, v-myc, and v-tcr proviruses in secondary tumors. J Virol (1992) 0.86
Skewed T-cell receptor Vbeta8.2 expression in transgenic CD2-myc induced thymic lymphoma: a role for antigen stimulation in tumour development? Br J Cancer (1997) 0.78
Apparent uncoupling of oncogenicity from fibroblast transformation and apoptosis in a mutant myc gene transduced by feline leukemia virus. J Virol (1996) 0.78
Molecular and immunophenotypical characterization of a feline immunodeficiency virus (FIV)-associated lymphoma: a direct role for FIV in B-lymphocyte transformation? J Virol (1998) 0.77
Transcriptional regulation of the human c-myc gene. Br J Cancer Suppl (1988) 0.77
Immunohistochemical identification of B and T lymphocytes in formalin-fixed, paraffin-embedded feline lymphosarcomas: relation to feline leukemia virus status, tumor site, and patient age. Can J Vet Res (1996) 0.77
The path well traveled: using mammalian retroviruses to guide research on XMRV. Mol Interv (2010) 0.76
Receptor-mediated leukaemogenesis: hypothesis revisited. Br J Cancer Suppl (1988) 0.76
Notch2 transduction by feline leukemia virus in a naturally infected cat. J Vet Med Sci (2013) 0.75
Retroviruses. Arch Dis Child (1987) 0.75
Presence of a Shared 5'-Leader Sequence in Ancestral Human and Mammalian Retroviruses and its Transduction into Feline Leukemia Virus. J Virol (2017) 0.75
An improved technique for obtaining enhanced infectivity with herpes simplex virus type 1 DNA. J Gen Virol (1976) 8.07
Temporal regulation of herpes simplex virus type 1 transcription: location of transcripts on the viral genome. Cell (1977) 7.60
Medical student selection: a tentative attempt to establish a code of practice. Br Med J (1980) 7.21
Physical mapping of herpes simplex virus-induced polypeptides. J Virol (1978) 6.08
Lymphocyte transformation in vitro measured by tritiated thymidine uptake. I. Lymphocyte culture techniques. Int Arch Allergy Appl Immunol (1970) 5.67
Hybrid plasmids containing an active thymidine kinase gene of Herpes simplex virus 1. Nucleic Acids Res (1979) 5.55
Recombinants between herpes simplex virus types 1 and 2: analyses of genome structures and expression of immediate early polypeptides. J Virol (1978) 4.87
Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science (2000) 4.48
Virulence of antibiotic-resistant Salmonella typhimurium. Proc Natl Acad Sci U S A (1998) 4.28
Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature (1991) 3.86
Consultation length and outcome in two group general practices. J R Coll Gen Pract (1983) 3.76
Nucleotide sequences of the joint between the L and S segments of herpes simplex virus types 1 and 2. J Gen Virol (1981) 3.70
Physical maps for Herpes simplex virus type 1 DNA for restriction endonucleases Hind III, Hpa-1, and X. bad. J Virol (1976) 3.56
Brief report: fulminating fat embolism syndrome caused by paradoxical embolism through a patent foramen ovale. N Engl J Med (1993) 3.55
Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature (1990) 3.29
Malignant transformation of early passage rodent cells by a single mutated human oncogene. Nature (1984) 3.24
Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol (1996) 3.20
Analysis of herpesvirus DNA substructure by means of restriction endonucleases. J Gen Virol (1976) 3.19
The synthesis and substructure of herpesvirus DNA: the distribution of alkali-labile single strand interruptions in HSV-1 DNA. J Gen Virol (1973) 3.15
Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus. Mol Microbiol (2001) 2.94
Physical mapping of herpes simplex virus type 1 mutations by marker rescue. J Virol (1978) 2.86
Paper and people: the work of the casualty reception clerk. Sociol Health Illn (1989) 2.54
Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. Nature (2000) 2.41
Physical mapping of paar mutations of herpes simplex virus type 1 and type 2 by intertypic marker rescue. J Virol (1979) 2.41
Prospective analysis of stoma-related complications. Colorectal Dis (2005) 2.35
Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses. J Virol (1986) 2.34
Post-traumatic stress disorder in the community: an epidemiological study. Psychol Med (1991) 2.34
Disappointing sensitivity of endoscopic markers for villous atrophy in a high-risk population: implications for celiac disease diagnosis during routine endoscopy. Am J Gastroenterol (2001) 2.30
Transcriptional regulation of a herpes simplex virus immediate early gene is mediated through an enhancer-type sequence. EMBO J (1984) 2.29
Location and orientation of homologous sequences in the genomes of five herpesviruses. J Gen Virol (1983) 2.29
The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock. J Exp Med (1997) 2.28
Outcome of the prenatally diagnosed congenital cystic adenomatoid lung malformation: a Canadian experience. Fetal Diagn Ther (2001) 2.18
Homologous tyrosine phosphorylation sites in transformation-specific gene products of distinct avian sarcoma viruses. Nature (1981) 2.11
Physical and genetic analysis of the herpes simplex virus DNA polymerase locus. Virology (1980) 2.11
Comparison of six in-house tests for the rapid diagnosis of feline immunodeficiency and feline leukaemia virus infections. Vet Rec (2001) 2.08
Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature (1993) 2.04
RCPE UK consensus statement on diabetes. J R Coll Physicians Edinb (2010) 2.03
Tyrosine-specific protein kinase activity associated with p105 of avian sarcoma virus PRCII. Virology (1981) 2.03
Horizontal transmission of leukemia virus and leukemia in the cat. J Natl Cancer Inst (1973) 2.00
Comparison of sevoflurane and propofol with rocuronium for modified rapid-sequence induction of anaesthesia. Anaesthesia (1999) 1.98
Prevalence of celiac disease and its endoscopic markers among patients having routine upper gastrointestinal endoscopy. Am J Gastroenterol (1999) 1.93
Thymidine kinase deletion mutants of herpes simplex virus type 1. J Gen Virol (1982) 1.84
Infectious herpesvirus DNA. Nat New Biol (1973) 1.82
Characterization of temperature-sensitive mutants of adenovirus type 5: nucleic acid synthesis. Virology (1973) 1.81
Structure of a mutant EF-G reveals domain III and possibly the fusidic acid binding site. J Mol Biol (2000) 1.78
Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals. Mol Cell Biol (1999) 1.77
Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene. J Cell Physiol (2000) 1.76
The structure and biological properties of herpes simplex virus DNA. Cold Spring Harb Symp Quant Biol (1975) 1.76
Novel ribosomal mutations affecting translational accuracy, antibiotic resistance and virulence of Salmonella typhimurium. Mol Microbiol (1999) 1.75
Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse. J Cell Sci (1994) 1.74
Fusidic acid-resistant mutants define three regions in elongation factor G of Salmonella typhimurium. Gene (1994) 1.74
Lateral spine radiographs before androgen deprivation treatment detect a high incidence of undiagnosed vertebral fragility fractures in men with advanced prostate cancer. J Urol (2011) 1.72
Transcriptional control signals in the genome of bovine papillomavirus type 1. Nature (1983) 1.70
Bolus dose remifentanil for control of haemodynamic response to tracheal intubation during rapid sequence induction of anaesthesia. Br J Anaesth (1999) 1.69
Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene. Proc Natl Acad Sci U S A (1997) 1.69
Characterization of a 105,000 molecular weight gag-related phosphoprotein from cells transformed by the defective avian sarcoma virus PRCII. Virology (1981) 1.67
The frequency of occurrence of feline leukaemia virus subgroups in cats. Int J Cancer (1978) 1.66
Head injuries: a study evaluating the impact of the NICE head injury guidelines. Emerg Med J (2005) 1.66
The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood (1998) 1.66
Determinants of the host range of feline leukaemia viruses. J Gen Virol (1973) 1.64
Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet (2005) 1.63
Muller's ratchet decreases fitness of a DNA-based microbe. Proc Natl Acad Sci U S A (1996) 1.63
Isolation of Yersinia enterocolitica from milk and a dairy farm in Australia. J Appl Bacteriol (1979) 1.63
Biology of feline leukemia virus in the natural environment. Cancer Res (1976) 1.59
Physical mapping of temperature-sensitive mutations of herpes simplex virus type 1 by intertypic marker rescue. Virology (1978) 1.58
Physical maps for HSV type 2 DNA with five restriction endonucleases. J Gen Virol (1978) 1.54
Case clustering, Epstein-Barr virus Reed-Sternberg cell status and herpes virus serology in Hodgkin's disease: results of a case-control study. Eur J Cancer (1995) 1.52
Lack of mature B cells in nude mice with X-linked immune deficiency. J Exp Med (1982) 1.52
Increased cholecystectomy rate in the laparoscopic era: a study of the potential causative factors. Surg Endosc (2006) 1.50
Community health monitoring: taking the pulse of America's children. Matern Child Health J (1998) 1.47
Common mechanism of infection by lentiviruses. Nature (1997) 1.47
Relationship among Lewis phenotype, clotting factors, and other cardiovascular risk factors in young adults. J Lab Clin Med (1995) 1.46
Lymphocyte transformation in multiple sclerosis. Inhibition of unstimulated thymidine uptake by a serum factor. Lancet (1968) 1.46
Activated ras oncogenes in human thyroid cancers. Cancer Res (1988) 1.45
The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein. Oncogene (2001) 1.45
Molecular mechanisms of anaesthesia: light at the end of the channel? Br J Anaesth (1998) 1.44
Feline leukemia virus envelope gp70 of subgroups B and C defined by monoclonal antibodies with cytotoxic and neutralizing functions. J Immunol (1983) 1.44
Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology (1994) 1.43
Homologous recombination between the tuf genes of Salmonella typhimurium. J Mol Biol (1996) 1.43
Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus in cats in the United Kingdom. Vet Rec (1989) 1.43
Resistance of herpes simplex virus to acycloguanosine--genetic and physical analysis. Virology (1980) 1.43
Clinical trial of iron therapy of psychomotor function in anaemic women. Br Med J (1970) 1.41
Invasion of neurones in vitro by non immune lymphocytes. An electron microscopic study. Br J Exp Pathol (1968) 1.41
Transgenic science. Br Vet J (1994) 1.41
Low-dose clonidine infusion during labour. Br J Anaesth (1999) 1.40
Vaccination against feline leukaemia virus. Vet Rec (1994) 1.39
Junctional epidermolysis bullosa with pyloric stenosis presenting with electron microscopic findings suggestive of epidermolysis bullosa simplex. Pediatr Dermatol (2001) 1.39
Use of hyperbaric oxygen in rheumatic diseases: case report and critical analysis. Lupus (1995) 1.39
Is midwifery safe in the embrace of the UKCC? Midwives (1995) (1995) 1.38
Benign vaginal polyp: a histological, histochemical and immunohistochemical study of 20 polyps with comparison to normal vaginal subepithelial layer. Histopathology (1992) 1.38
Host-specificities of papillomavirus, Moloney murine sarcoma virus and simian virus 40 enhancer sequences. EMBO J (1983) 1.38
Sequence heterogeneity and anomalous electrophoretic mobility of kinetoplast minicircle DNA from Leishmania tarentolae. Gene (1984) 1.36
Lymphocyte trnsformation induced by encephalitogenic factor in multiple sclerosis and other neurological diseases. Lancet (1968) 1.36
Prevalence of antibody to human herpesvirus 7 by age. J Infect Dis (1993) 1.36
Persistence and transmission of natural type I feline coronavirus infection. J Gen Virol (2003) 1.36
Explaining oropharyngeal dysphagia after unilateral hemispheric stroke. Lancet (1997) 1.36
Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss. Oncogene (1995) 1.35